 |
|
Ocular Inflammatory Disease in the New Millennium
Annabelle A. Okada, MD;
John V. Forrester, MD
Arch Ophthalmol. 2000;118:116-119.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
As we enter the year 2000, we are asked to consider what advances may occur in the field of ocular inflammatory disease in the next 50 to 100 years. This is a daunting and probably unwise endeavor, but an extremely interesting one.
The diagnosis and treatment of ocular inflammatory disease began as a scientific discipline in the 17th century, with the recognition of infectious diseases, such as gonorrhea, that can affect the eye.1 Thereafter, for the better part of the next 2 centuries, most all ocular inflammatory diseases were considered infectious in nature, with syphilis and tuberculosis believed to be the primary culprits. As such, demonstration of the efficacy of antibiotics in treating such infections was a major medical milestone of the 20th century. However, not all cases of ocular inflammation responded to antibiotics, and theories began to appear suggesting that "autoimmunity" . . . [Full Text of this Article]
ADVANCES IN PATHOGENIC MECHANISMS AND DIAGNOSTIC TECHNIQUES
RECOGNITION OF OCULAR DISEASES CAUSED BY NEW INFECTIOUS AGENTS
BLURRING OF THE DISTINCTION BETWEEN INFECTIOUS AND NONINFECTIOUS FORMS OF OCULAR INFLAMMATORY DISEASE
NEW INVESTIGATIVE TOOLS
ADVANCES IN THERAPEUTIC MODALITIES
Gene Therapy for Ocular Inflammatory Disease Monoclonal Antibody Technology for Ocular Inflammatory Disease Antigen-Specific Tolerizing Therapy
BEYOND OUR WILDEST DREAMS?
From the Departments of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan (Dr Okada), and University of Aberdeen Medical School Forresterhill, Aberdeen, Scotland (Dr Forrester).
RELATED ARTICLE
Ophthalmology in the New Century
Leonard A. Levin
Arch Ophthalmol. 2000;118(1):116.
EXTRACT
| FULL TEXT
|
